NCCN, ESMO and Cancer Australia recognize scalp cooling as standard of care

National Comprehensive Cancer Network® (NCCN)

  • Scalp cooling is a Category 2A recommendation to reduce the incidence of chemotherapy-induced alopecia for patients receiving chemotherapy.
  • For NCCN scalp cooling recommendations view the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

    – Breast cancer (Version 1.2019) – Category 2A recommendation

    – Ovarian cancer (Version 1.2020) – Category 2A recommendation

European Society for Medical Oncology (ESMO)

Cancer Australia